K138N (p.Lys138Asn) variant of PON1 (Serum paraoxonase/arylesterase 1)
K138N (p.Lys138Asn) in PON1 (Serum paraoxonase/arylesterase 1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.15 / 1. The record also includes population frequency data and structural context.
K138N (p.Lys138Asn) variant details
- p.Lys138Asn
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.152
- REVEL 0.06
- CADD 16.40
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available